Related references
Note: Only part of the references are listed.Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans
Krishnaraj S. Rathod et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
Charles N. Serhan
FASEB JOURNAL (2017)
Immune resolution mechanisms in inflammatory arthritis
Mauro Perretti et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis
Lillian J. Barra et al.
RHEUMATOLOGY (2017)
Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Christian Pfluecke et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
Synthesis of 13 (R)-Hyd roxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins
Karoline G. Primdahl et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Resolution of inflammation: a new therapeutic frontier
James N. Fullerton et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Human neutrophils in auto-immunity
Nathalie Thieblemont et al.
SEMINARS IN IMMUNOLOGY (2016)
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
Gabrielle Fredman et al.
NATURE COMMUNICATIONS (2016)
The clinical significance of hematologic parameters in patients with sarcoidosis
Nigar Dirican et al.
CLINICAL RESPIRATORY JOURNAL (2016)
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Lucy V. Norling et al.
JCI INSIGHT (2016)
Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice
Jon T. Giles
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2015)
Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment
Mio Akiyama et al.
CLINICAL RHEUMATOLOGY (2015)
Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
Jesmond Dalli et al.
NATURE MEDICINE (2015)
Pathways involved in the resolution of inflammatory joint disease
Oliver Haworth et al.
SEMINARS IN IMMUNOLOGY (2015)
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
Romain A. Colas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1
Masakazu Shinohara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
Kathrin Danninger et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2014)
Nonclassical Ly6C- Monocytes Drive the Development of Inflammatory Arthritis in Mice
Alexander V. Misharin et al.
CELL REPORTS (2014)
Statin Therapy for Primary Prevention of Cardiovascular Disease
Fiona C. Taylor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab - preclinical and clinical studies
Dorothee Kling et al.
THROMBOSIS RESEARCH (2013)
Modulation of neutrophil apoptosis and the resolution of inflammation through β2 integrins
Driss El Kebir et al.
FRONTIERS IN IMMUNOLOGY (2013)
Quantitative Analysis of Monocyte Subpopulations in Murine Atherosclerotic Plaques by Multiphoton Microscopy
Abigail S. Haka et al.
PLOS ONE (2012)
Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
Driss El Kebir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Novel Lipid Mediators Promote Resolution of Acute Inflammation Impact of Aspirin and Statins
Matthew Spite et al.
CIRCULATION RESEARCH (2010)
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4
A. Planaguma et al.
MUCOSAL IMMUNOLOGY (2010)
Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment
I. V. Shirinsky et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
Pertti J. Neuvonen et al.
CLINICAL PHARMACOKINETICS (2008)
Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis
Kaisa M. Maeki-Petaejae et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat
Yochai Birnbaum et al.
CIRCULATION (2006)
Targeting the stromal microenvironment in chronic inflammation
Andrew Filer et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Share Paper
